Search - tctmd.com

Displaying 61 - 80 of 172

Sort: Relevancy | Date

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

News Conference News ESC 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Yael L. Maxwell

September 08, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

STEMI Spectrum in COVID-19 Captured by Multinational Case Series

Caitlin E. Cox

July 08, 2020

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

News Daily News

Most Stable Angina Patients Not Taking First-line Meds

Shelley Wood

June 18, 2020

News Daily News

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

L.A. McKeown

June 17, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF

Caitlin E. Cox

March 02, 2020

News Daily News

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Shelley Wood

January 20, 2020

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

News Daily News

Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms

Caitlin E. Cox

November 15, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Conference News ESC 2019

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

Yael L. Maxwell

September 04, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

Advertisement

Study Affirms Thrombotic Risk in COVID-19

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

STEMI Spectrum in COVID-19 Captured by Multinational Case Series

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Most Stable Angina Patients Not Taking First-line Meds

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content